| Dr Donald Ansel Presley, DMD | |
|
692 Grisham Street, Baldwyn, MS 38824-0247 | |
| (662) 365-7814 | |
| (662) 365-7643 |
| Full Name | Dr Donald Ansel Presley |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 692 Grisham Street, Baldwyn, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568677797 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | MS 2355-87 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Donald Ansel Presley, DMD Po Box 247, Baldwyn, MS 38824-0247 Ph: (662) 365-7814 | Dr Donald Ansel Presley, DMD 692 Grisham Street, Baldwyn, MS 38824-0247 Ph: (662) 365-7814 |
News Archive
Scientists are a step closer to understanding what controls fine particulate matter in the Earth's atmosphere after identifying new linkages between natural contaminants and with manmade pollutants.
The Association of Academic Health Centers (AAHC) launched the Education and Training Clinical Research Compliance Tool designed to assist academic health center leaders, research administrators, compliance and clinical trials office administrators, and directors of compliance education and training in strengthening and improving the development and implementation of clinical research compliance education and training programs.
Some children who are accurately diagnosed in early childhood with autism lose the symptoms and the diagnosis as they grow older, a study supported by the National Institutes of Health has conf​irmed. The research team made the finding by carefully documenting a prior diagnosis of autism in a small group of school-age children and young adults with no current symptoms of the disorder.
Catalyst Pharmaceutical Partners, Inc., a biopharmaceutical company that acquires, in-licenses, develops and commercializes prescription drugs for the treatment of diseases of the central nervous system, today reported financial results for the fourth quarter and year ended December 31, 2009.
Anadys Pharmaceuticals, Inc. announced today the pricing of its underwritten public offering of 13,888,889 shares of its common stock at a price to the public of $1.80 per share. The gross proceeds to Anadys from this offering are expected to be approximately $25.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses.
› Verified 8 days ago
Dr. Leland Moore Roberts, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 110 S 3rd St, Baldwyn, MS 38824 Phone: 662-365-3154 Fax: 662-365-3157 |